EXHIBIT 99.2

           Greatbatch Announces Acquisition of Quan Emerteq

            Broadens Greatbatch Presence in Vascular Market

    CLARENCE, N.Y.--(BUSINESS WIRE)--Oct. 30, 2007--Greatbatch, Inc.
(the "Company") (NYSE:GB) announced today that they have signed a
definitive asset purchase agreement to acquire Quan Emerteq LLC for
approximately $55 million in cash. The Company expects to close this
transaction in November 2007. Quan Emerteq, based in Blaine,
Minnesota, a suburb of Minneapolis, designs, develops and manufactures
single use medical device products for the vascular, cardiac rhythm
management and neurostimulation markets.

    The Company anticipates that Quan Emerteq will have annual sales
in the range of $20-$24 million for 2007. Excluding one-time purchase
accounting adjustments, such as in-process R&D charges, earnings are
expected to be neutral in 2007 & 2008 and accretive thereafter.

    Quan Emerteq's main product lines consist of the following:

    Delivery Systems: Manufactures a broad line of catheters for use
in multiple cardiology applications that cover the coronary,
peripheral, and neurovascular market space. This includes products for
the delivery of stents for peripheral and high growth carotid
indications, catheters for delivery of PFO closure devices, PAD
catheter based devices, imaging catheters, as well as other
indications. This segment of Quan Emerteq's product experience also
includes catheters in the space of drug and device convergence, as
well as catheters delivering drugs and stem cells to targeted
locations in the body.

    Stimulation Catheters: Targets stimulation markets in the EP
catheter lab. This includes navigation technology to aid access for
devices in Cardiac Resynchronization Therapy, and Ablation therapies,
including the rapidly growing AF segment.

    Leadwires: Provides value at multiple levels across stimulation
lead design, development, and manufacturing to support cardiac and
neurostimulation markets. The integrated capabilities provide in-house
support to rapidly develop and manufacture leads.

    Micro Components and Assemblies: A leading supplier to major
device industry players through their components business: providing
micro molded and machined components and assemblies for use in OEM
build processes. Their capabilities serve high tolerance niches within
their market space and will further support Greatbatch's existing
needs for these critical components.

    Quan Emerteq core competencies include:

    --  Design, Development and Manufacturing of vascular catheters
        and stimulation leads leveraging vertically integrated
        capabilities of:

        --  Extrusion

        --  Molding

        --  Machining

        --  Coiling

        --  Braiding

        --  Hydrophilic Coating

    These capabilities add to and expand the existing levels of
integration within the Greatbatch organization.

    Thomas Hook, Greatbatch President and CEO stated, "The acquisition
of Quan Emerteq expands our vascular market presence into the
peripheral, coronary and neurovascular markets and broadens our
existing CRM and neurostimulation product offerings. This acquisition
provides revenue growth opportunities to sell our expanded product
portfolio to existing customers as well as diversifies our customer
base with the addition of several new blue chip medical device
companies. The addition of Quan Emerteq to our existing Enpath
business creates critical mass in the growing vascular market. We
welcome the employees of Quan Emerteq to the Greatbatch team and look
forward to working with them and their strong management team."

    About Greatbatch, Inc.

    Greatbatch, Inc. (NYSE: GB) is a leading developer and
manufacturer of critical components used in medical devices for the
cardiac rhythm management, neurostimulation, vascular and
interventional radiology markets. Additionally, Electrochem Commercial
Power, a subsidiary of Greatbatch, is a world leader in the design and
manufacture of lithium cells and battery packs for demanding
applications such as oil and gas exploration, pipeline inspection,
military, asset tracking, oceanography and seismic surveying.
Additional information about the Company is available at
www.greatbatch.com.

    CONTACT: Greatbatch, Inc.
             Anthony W. Borowicz, 716-759-5809
             Treasurer and Director, Investor Relations,
             tborowicz@greatbatch.com